510(k) Report

510(k) · Cleared

Cleared

Modification of Encore Linear Porous Coated Hip

K991325510(k) TraditionalCleared Jun 25, 199967-day reviewClass II21 CFR 888.3358

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Encore Orthopedics, Inc. · LPH Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Porous Uncemented

Cleared on Jun 25, 1999 after a 67-day review. The FDA summary names no predicate by number. 14 later devices descend from it.

Decided
Jun 25, 1999
Review
67 days
Class
Class II
Product code
LPH
Recalls
None
Predicates
0

14 later devices descend from it, 3 citing it directly.

Descendants, by year cleared 2014: 2 descendants cleared2012: 1 descendant cleared2023: 3 descendants cleared2013: 1 descendant cleared2015: 2 descendants cleared2016: 2 descendants cleared2017: 2 descendants cleared2026: 1 descendant cleared1995200020052010201520202025
  1. This deviceK991325 Modification of Encore Linear Porous Coated HipEncore Orthopedics, Inc. · 1999
  2. Descendant · cites it directly · 6 of its ownK120241 Linear Hip Stem, Size 5Encore Medical L.P. · 2012 · Recalled
  3. Descendant · cites it directly · 5 of its ownK141327 Minima S SystemLima Corporate S.P.A. · 2014
  4. Descendant · cites it directly · 4 of its ownK140975 Mastersl Femoral StemLima Corporate S.P.A. · 2014
  5. Descendant · 2 generations on · 4 of its ownK130099 Taperfill Femoral Hip Stem 425-31-005_017 425-41-005_019Encore Medical L.P. · 2013
  6. Descendant · 2 generations on · 3 of its ownK143509 MasterSL femoral stemLima Corporate S.P.A. · 2015

Showing 5 of 14 descendants. See all descendants

Descendants cleared per year

2012: 12013: 12014: 22015: 22016: 22017: 22023: 32026: 1
2012high 3 (2023) · low 0 (2018)2026

Most influential descendants

Showing 5 of 14 · See all
  • K120241Linear Hip Stem, Size 5Encore Medical L.P. · 2012 · cites it directly6descendants
  • K141327Minima S SystemLima Corporate S.P.A. · 2014 · cites it directly5descendants
  • K140975Mastersl Femoral StemLima Corporate S.P.A. · 2014 · cites it directly4descendants
  • K130099Taperfill Femoral Hip Stem 425-31-005_017 425-41-005_019Encore Medical L.P. · 2013 · 2 generations on4descendants
  • K143509MasterSL femoral stemLima Corporate S.P.A. · 2015 · 2 generations on3descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K991325Modification of Encore Linear Porous Coated HipEncore Orthopedics, Inc.1999—
+1K120241Linear Hip Stem, Size 5Encore Medical L.P.20121
+1K141327Minima S SystemLima Corporate S.P.A.2014—
+1K140975Mastersl Femoral StemLima Corporate S.P.A.2014—
+2K130099Taperfill Femoral Hip Stem 425-31-005_017 425-41-005_019Encore Medical L.P.2013—
+2K143509MasterSL femoral stemLima Corporate S.P.A.2015—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201210
201310
201420
201520
201620
201720
202330
202610
FIG. 1 — Lineage of K991325, 1999–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LPH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LPH device

  1. #1 K233498 Stryker Orthopaedics Hip Systems Labeling Updatescore 24.3 · 20 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

The FDA summary names no predicate by number.

What descends from it? (14)

See all 14

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K120241Linear Hip Stem, Size 5Encore Medical L.P.20126
K141327Minima S SystemLima Corporate S.P.A.20145
K140975Mastersl Femoral StemLima Corporate S.P.A.20144

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K120241 (Encore Medical L.P., 2012) has gone furthest, with 6 descendants of its own.

How does its category compare?

All LPH devices

LPH Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Porous Uncemented: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LPH

12in 2025

2007: 102008: 102009: 32010: 152011: 162012: 252013: 112014: 202015: 182016: 102017: 122018: 92019: 222020: 72021: 82022: 142023: 102024: 62025: 122026 (partial year): 8
2007high 25 (2012) · low 3 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LPH

153in 2025

2007: 116 days median2008: 86 days median2009: 112 days median2010: 100 days median2011: 110 days median2012: 76 days median2013: 135 days median2014: 129 days median2015: 111 days median2016: 150 days median2017: 121 days median2018: 145 days median2019: 164 days median2020: 164 days median2021: 410 days median2022: 247 days median2023: 111 days median2024: 92 days median2025: 153 days median2026 (partial year): 256 days median
2007high 410 (2021) · low 76 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LPH

4in 2025

2007: 162008: 12009: 22010: 222011: 262012: 302013: 92014: 32015: 12016: 82017: 142018: 22019: 82020: 62021: 42022: 22023: 22024: 12025: 42026 (partial year): 2
2007high 30 (2012) · low 1 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LPH

6,163in 2025

2007: 5092008: 7062009: 1,1562010: 2,0072011: 3,3202012: 3,7852013: 5,0022014: 5,1632015: 5,8302016: 4,9002017: 5,3122018: 5,9542019: 7,1302020: 5,4292021: 5,9782022: 5,2232023: 5,3452024: 5,6262025: 6,163
2007high 7,130 (2019) · low 509 (2007)2025

MAUDE reports naming product code LPH, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071011616509
200810861706
2009311221,156
201015100222,007
201116110263,320
20122576303,785
20131113595,002
20142012935,163
20151811115,830
20161015084,900
201712121145,312
2018914525,954
20192216487,130
2020716465,429
2021841045,978
20221424725,223
20231011125,345
202469215,626
20251215346,163
202682562—

What is it indicated for?

The indications for use of the total hip replacement prosthesis include: noninflammatory degenerative joint disease including osteoarthritis and avascular necrosis; rheumatoid arthritis; correction of functional deformity; revision procedures where other treatments or devices have failed; and treatment of nonunion, femoral neck and trochanteric fractures of the proximal femur with head involvement, which is unmanageable using other techniques. This stem is to be press-fit.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K991325: Modification of Encore Linear Porous Coated Hip.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K991325

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026